Advertisement
Advertisement
U.S. Markets open in 1 hr 13 mins
Advertisement
Advertisement
Advertisement
Advertisement

Lattice Biologics Ltd. (LBLTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.01400.0000 (0.00%)
At close: 02:36PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0140
Open0.0140
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0140 - 0.0140
52 Week Range0.0133 - 0.5684
Volume13,571
Avg. Volume792
Market Cap1.795M
Beta (5Y Monthly)-11.71
PE Ratio (TTM)N/A
EPS (TTM)-0.0070
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading

    ISLAND PARK, Id., July 09, 2021--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") announces financial results for Q2 2021.

  • CNW Group

    IIROC Trading Halt - LBL

    The following issues have been halted by IIROC:

  • Business Wire

    Lattice Announces Strategic Advisory Board

    Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice" or the "Company"), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Lattice’s executive team as it continues to build and strengthen the Company's portfolio of cannabis and psilocybin related brands and products

Advertisement
Advertisement